Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluting Everolimus From Cobalt Versus Platinum Alloy Platforms.

NCT01776567 is registered in ClinicalTrials.gov with Northern Hospital, Australia as lead sponsor.

NCT NCT01776567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01776567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluting Everolimus From Cobalt Versus Platinum Alloy Platforms.
Lead sponsor
Northern Hospital, Australia
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2012
Completion date
June 30, 2015
Enrollment
60 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease